ARS Pharmaceuticals (SPRY) Earnings Date & Reports

ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the commercialization and development of neffy (currently identified in the European Union (EU) and United Kingdom (U... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

SPRY is expected to report earnings to fall 53.81% to -29 cents per share on November 17

ARS Pharmaceuticals SPRY Stock Earnings Reports

Q3'26

Est.

$-0.29

Q2'26

Missed

by $0.13

Q1'26

Missed

by $0.12

Q4'25

Beat

by $0.01

Q3'25

Missed

by $0.06

The last earnings report on August 13 showed earnings per share of -62 cents, missing the estimate of -50 cents. With 813.70K shares outstanding, the current market capitalization sits at 547.46M.

View a ticker or compare two or three

SPRY

Daily Signal:

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days